The event gathered more than 1,000 experts and medical staff, with the chairmanship of leading professors and doctors in the field of pediatrics and epidemiology.
At the workshop, experts updated the latest epidemiological data, emphasizing that children under 5 years old are the most at risk of highly toxic bacterial plaque tubes. According to the WHO, streptococcal disease kills about 1.6 million people each year, of which nearly 1 million are children.
Reports at the workshop affirmed the need to implement an early prevention strategy, covering a wide range of circulating serotypes. Vaccination continues to be recommended as the most effective measure to help reduce the burden of disease and create an "immunity shield" for the community.
Pfizer representative, Dr. Mark Fletcher said that the heritage combination vaccine has proven effective in more than 160 countries, which is an important foundation for expanding the scope of child protection in the future. The series of seminars is an activity to enhance international experience exchange and raise public awareness of the prevention of bronchial disease.
